# Warp Sciences raises $215M Series A to apply AI and robotics to drug discovery

> Original title: Lieutenant Colonel Kevin Weil emerging from stealth with $215m in funding from a Series A! Warp Sciences is using AI and robots to make a...

- Source: Andrew Curran
- Published: 2026-10-22T17:54:41.000Z
- Bad Influence: https://badinfluence.news/items/qpzwxvxpqufolfoz7ejp5tbyy
- Original: https://x.com/AndrewCurran_/status/2113328200822796357

## Summary

Warp Sciences, founded by former OpenAI CPO Kevin Weil, emerged from stealth with a $215M Series A led by Lightspeed. The company plans to make and test molecules for drug developers using AI and robotics, starting as a preclinical contract research organization in America.

## Why it matters

The post reports a $215M Series A for a company combining AI and robotics in drug testing, with its founder's OpenAI background explaining why the venture is notable.

## Post

Lieutenant Colonel Kevin Weil emerging from stealth with $215m in funding from a Series A! Warp Sciences is using AI and robots to make and test molecules for companies developing new drugs. He was OpenAI CPO, and was leading AI-for-science before he left to found Warp.

![](https://badinfluence.news/api/img-proxy?u=https%3A%2F%2Fpbs.twimg.com%2Fmedia%2FHVQMzB2b0AEio_b.jpg&mode=thumb&exp=1793404800&sig=f7ddab831b0c854e)

## Quoted post @kevinweil

> 💥 Introducing Warp Sciences, a new company applying AI and robotics to help the world develop new medicines faster. 
> 
> We’ve raised a $215M Series A led by @lightspeedvp to bring frontier AI out of the browser and into the lab, and build scientific capacity here in America.
> 
> I co-founded Warp with my long-time friend @dpatil, FAIR co-founder @manohar_paluri, and drug hunter Sol Reisberg. The early team is full of incredible people like @bkspears9, who helped achieve Q>1 fusion at LLNL.

https://x.com/kevinweil/status/2113294657673466060